Cargando…

Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer

BACKGROUND: Although circulating tumor cells (CTCs) are considered as a surrogate marker in monitoring disease progression and treatment response in late stage prostate cancer (PCa), its clinical impact in localized PCa remains unclear, indicating the limitation that is simply based on cell count. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hailong, Ding, Jie, Wu, Yanyuan, Wu, Di, Qi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304675/ https://www.ncbi.nlm.nih.gov/pubmed/32606948 http://dx.doi.org/10.2147/CMAR.S253997

Ejemplares similares

Epithelial-Mesenchymal Transition and Breast Cancer
por: Wu, Yanyuan, et al.
Publicado: (2016)

Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin
por: Yang, Faying, et al.
Publicado: (2020)

Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
por: Broncy, Lucile, et al.
Publicado: (2019)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case
por: Chai, Shoujie, et al.
Publicado: (2022)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients
por: Cha, Jiwon, et al.
Publicado: (2023)

Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications
por: Jie, Xiao-Xiang, et al.
Publicado: (2017)

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?
por: Khan, Tanzila, et al.
Publicado: (2020)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer
por: Zhao, Ren, et al.
Publicado: (2016)

Aspirin inhibit platelet-induced epithelial-to-mesenchymal transition of circulating tumor cells (Review)
por: LOU, XIAO-LIANG, et al.
Publicado: (2014)

Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance
por: Zhou, Jiaojiao, et al.
Publicado: (2020)

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
por: CHUNG, SEYUNG S., et al.
Publicado: (2013)

TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts
por: Huang, Guangcun, et al.
Publicado: (2016)

Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer
por: Wu, Fengjie, et al.
Publicado: (2017)

Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer
por: Lowes, Lori E., et al.
Publicado: (2016)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer
por: Hennigan, S. Thomas, et al.
Publicado: (2019)

Epithelial-mesenchymal transition classification of circulating tumor cells in lung and colon cancer patients: potential role in clinical practice
por: Fang, Jinman, et al.
Publicado: (2020)

Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients
por: Zhang, Ruiyun, et al.
Publicado: (2020)

Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition
por: Yang, Jiani, et al.
Publicado: (2021)

Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells
por: Barrière, Guislaine, et al.
Publicado: (2012)

Cancer metastasis through the prism of epithelial‐to‐mesenchymal transition in circulating tumor cells
por: Micalizzi, Douglas S., et al.
Publicado: (2017)

Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial–Mesenchymal Plasticity
por: McInnes, Linda M., et al.
Publicado: (2015)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
por: Di Zazzo, Erika, et al.
Publicado: (2019)

Epithelial-Mesenchymal Transition in Keratocystic Odontogenic Tumor: Possible Role in Locally Aggressive Behavior
por: Zhong, Wen-Qun, et al.
Publicado: (2015)

Epithelial-mesenchymal transition in prostate cancer: an overview
por: Montanari, Micaela, et al.
Publicado: (2017)

Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells
por: Guan, Xiuwen, et al.
Publicado: (2016)

Understanding of mouse and human bladder at single‐cell resolution: integrated analysis of trajectory and cell‐cell interactive networks based on multiple scRNA‐seq datasets
por: Shi, Bowen, et al.
Publicado: (2021)

PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice
por: Hong, Xiao-Cui, et al.
Publicado: (2022)

Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
por: Zhao, Qiang, et al.
Publicado: (2022)

Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer
por: Mego, M., et al.
Publicado: (2015)

Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
por: Tashireva, Liubov A., et al.
Publicado: (2021)

Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination
por: Noubissi Nzeteu, Gaetan Aime, et al.
Publicado: (2022)

Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma
por: Pan, Yujin, et al.
Publicado: (2021)

Epithelial-mesenchymal transition classification of circulating tumor cells predicts clinical outcomes in progressive nasopharyngeal carcinoma
por: Wei, Jiazhang, et al.
Publicado: (2022)

Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?
por: Fridrichova, Ivana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lg1286lmu9f5q91optjrjlouqa